FINAL THOUGHT Glow is safest when its supported by regulation, not shortcuts
However, glycine does not directly address B12 deficiency, which is a real risk during prolonged GLP-1 therapy
The studies also found that one in three participants taking Zepbound at the highest dose lost over 58 lbs or 25% of their body weight
If there's insulin resistance, if there are, uh, metabolic comorbidities, like there's already pre-diabetes type two diabetes, fatty liver disease, there's elevated cardiovascular risk that [00:41:00] is not improving despite trying everything, doing everything right, then that's when GLP ones are considered
These products are not intended to diagnose, prevent, treat, or cure any disease